NEW YORK, Sept. 3 (GenomeWeb News) - Quorex Pharmaceuticals of Carlsbad, Calif., and IDEC Pharmaceuticals of San Diego today announced a research collaboration seeking novel genes encoding proteins for use as therapeutic targets for cancers and inflammatory disorders.
Quorex will apply its Protein Vision bioinformatics tools -- which include genome annotation, homology modeling, and protein-fold prediction tools -- and receive undisclosed up-front and research payments.